Stericycle (NASDAQ:SRCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Saturday.

SRCL has been the topic of a number of other research reports. Barclays reissued an “overweight” rating and issued a $100.00 target price on shares of Stericycle in a research note on Wednesday, August 9th. William Blair reissued an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Royal Bank Of Canada reduced their target price on Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a research note on Thursday, November 9th. BMO Capital Markets reduced their target price on Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a research note on Friday, November 10th. Finally, Jefferies Group set a $108.00 target price on Stericycle and gave the company a “buy” rating in a research note on Friday, August 11th. Four research analysts have rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $76.73.

Shares of Stericycle (NASDAQ:SRCL) traded up $0.63 during mid-day trading on Friday, hitting $66.94. The company had a trading volume of 855,494 shares, compared to its average volume of 932,289. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a one year low of $61.25 and a one year high of $88.00. The stock has a market capitalization of $5,710.00, a P/E ratio of 15.28, a PEG ratio of 1.62 and a beta of 0.19.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The business had revenue of $883.00 million during the quarter, compared to analysts’ expectations of $896.81 million. During the same quarter last year, the business posted $1.24 EPS. The company’s quarterly revenue was down .8% on a year-over-year basis. sell-side analysts predict that Stericycle will post 4.49 earnings per share for the current fiscal year.

In other news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $64.03, for a total transaction of $1,264,784.59. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have sold 59,259 shares of company stock worth $3,908,724 over the last ninety days. Insiders own 3.50% of the company’s stock.

Large investors have recently made changes to their positions in the company. Pacer Advisors Inc. grew its stake in shares of Stericycle by 8.4% during the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after buying an additional 145 shares during the last quarter. NEXT Financial Group Inc grew its stake in shares of Stericycle by 77.9% during the third quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock valued at $164,000 after buying an additional 1,017 shares during the last quarter. ARGI Investment Services LLC bought a new position in shares of Stericycle during the third quarter valued at about $215,000. Zions Bancorporation bought a new position in shares of Stericycle during the third quarter valued at about $233,000. Finally, Cadence Capital Management LLC bought a new position in shares of Stericycle during the third quarter valued at about $234,000. 94.59% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/02/stericycle-srcl-upgraded-to-sell-at-bidaskclub.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.